BC
EIGR

Broadfin Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Broadfin Capital’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		$18.4M Sell
41,212
-4,367
-10% -$1.95M 2.47% 7
2019
Q3 		$14M Sell
45,579
-9,626
-17% -$2.96M 2.59% 6
2019
Q2 		$17.6M Buy
55,205
+48,762
+757% +$15.5M 3.82% 8
2019
Q1 		$2.7M Buy
6,443
+1,666
+35% +$699K 0.56% 36
2018
Q4 		$1.46M Buy
+4,777
New +$1.46M 0.19% 42